Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Black Diamond Therapeutics (BDTX) Other Non Operating Income: 2018-2021

Historic Other Non Operating Income for Black Diamond Therapeutics (BDTX) over the last 4 years, with Dec 2021 value amounting to -$2.2 million.

  • Black Diamond Therapeutics' Other Non Operating Income rose 46.20% to -$375,000 in Q4 2021 from the same period last year, while for Dec 2021 it was -$2.3 million, marking a year-over-year decrease of 80.05%. This contributed to the annual value of -$2.2 million for FY2021, which is 26.91% down from last year.
  • Black Diamond Therapeutics' Other Non Operating Income amounted to -$2.2 million in FY2021, which was down 26.91% from -$1.7 million recorded in FY2020.
  • Over the past 5 years, Black Diamond Therapeutics' Other Non Operating Income peaked at -$16,000 during FY2018, and registered a low of -$6.4 million during FY2019.
  • Its 3-year average for Other Non Operating Income is -$3.4 million, with a median of -$2.2 million in 2021.
  • In the last 5 years, Black Diamond Therapeutics' Other Non Operating Income slumped by 39,856.25% in 2019 and then spiked by 73.03% in 2020.
  • Yearly analysis of 4 years shows Black Diamond Therapeutics' Other Non Operating Income stood at -$16,000 in 2018, then tumbled by 39,856.25% to -$6.4 million in 2019, then skyrocketed by 73.03% to -$1.7 million in 2020, then declined by 26.91% to -$2.2 million in 2021.